The decision has been taken in order to curb the sales of spurious medicines. Furthermore, this will also help in checking the authenticity...

The widely-used drug saw sales soar 20X during the third wave of the pandemic. It registered a 100% jump in January over the previous month...

A drop in the number of Covid cases has been reflected in the sales of multi-vitamin supplements that were once widely sold. A report by TO...

A 30-year-old brand manufactured by the little-known Apex Labs, Zincovit registered sales of Rs 50 crore during October, dethroning the lar...

Insulin brand Human Mixtard, oral formulation Glycomet GP, insulin Lantus, oral formulations Galvus Met and Janumet are now in the top-sell...

American firm Abbott Laboratories consolidated its top position in the Indian drug retail market by growing at a faster than its closest co...

Oral anti-diabetes segment grew 29.7% for the nine-month period ended August 2010 over the year ago period compared with 22.9% increase in ...

Drug price regulator National Pharmaceutical Pricing Authority allows cos to up MRP of popular insulin brands by 15%.

Novartis’ painkiller, Voveran, has emerged as the best-selling drug in the country.

Wockhardt is planning to restart production of human recombinant insulin Wosulin (50:50), for which the State Food and Drug Administration ...

Indian pharma companies which paid little focus on building brands will soon have to do so.